dbACP: A Comprehensive Database of Anti-Cancer Peptides

9 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp04859 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK Residue of 39-65 of porcine NK-lysine Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 4.3±0.3 µM
dbacp04860 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK Residue of 39-65 of porcine NK-lysine Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 70 µM (approx.)
dbacp04861 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK Residue of 39-65 of porcine NK-lysine Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 50 µM (approx.)
dbacp04862 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK Residue of 39-65 of porcine NK-lysine Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 50 µM (approx.)
dbacp04863 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK Residue of 39-65 of porcine NK-lysine Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 40 µM (approx.)
dbacp04864 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK NK-lysin Cell membrane disintegration PI-uptake assay NB LA-N-1 Colorectal cancer LD50 : 1-4 µM
dbacp04865 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK NK-lysin Cell membrane disintegration PI-uptake assay SH-SY5Y Brain tumor LD50 : 1-4 µM
dbacp04866 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK NK-lysin Cell membrane disintegration PI-uptake assay U-937 Lymphoma cancer LD50 : 30 µM
dbacp04867 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK NK-lysin Cell membrane disintegration PI-uptake assay SW-480 Leukemia cancer LD50 : 1-4 µM